Masimo (MASI)
(Delayed Data from NSDQ)
$134.01 USD
-0.40 (-0.30%)
Updated May 1, 2024 04:00 PM ET
After-Market: $133.95 -0.06 (-0.04%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MASI 134.01 -0.40(-0.30%)
Will MASI be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for MASI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MASI
Teleflex (TFX) Tops Q1 Earnings and Revenue Estimates
Will Masimo (MASI) Beat Estimates Again in Its Next Earnings Report?
MASI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Reasons Why You Should Retain Masimo (MASI) Stock for Now
Masimo (MASI) Gains Nearly 18% YTD: What's Driving the Rally?
Is a Beat Likely for Intuitive Surgical (ISRG) in Q1 Earnings?
Other News for MASI
Buy Rating Affirmed for Masimo Amidst Stable Financials and Strategic Business Optimism
Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024
Masimo Reaches Analyst Target Price
Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7
Ensemble Fund Q1 2024 Investment Update